Circadia Health
Michal Maslik began their work experience as a Technology Developer and Analyst Intern at Bank of America Merrill Lynch in 2014 and 2015. In 2016, they became the CTO & Co-Founder at Circadia Health, where they are currently working.
Michal Maslik began their educational journey in 2012 at Imperial College London, where they pursued a Master of Engineering (MEng) degree and also became an Associate of the City and Guilds Institute. Their field of study during this period was focused on Electrical and Electronics Engineering. Michal completed this program in 2016.
After their master's degree, Michal Maslik continued their education at Imperial College London, entering a Ph.D. program in Electrical Engineering Research. Michal specialized in Neural Microsystems as their field of study. Michal started this program in 2016 and is expected to complete it in 2021.
Circadia Health
Circadia improves clinical outcomes by using an FDA-approved truly contactless patient monitoring system to detect problems early. The technology measures a patient's respiratory rate from up to 8 feet away, with nothing on the bed or body required. Clinicians use this data to forecast medical events such as congestive heart failure, COPDexacerbations, pneumonia, sepsis, urinary tract infections, and falls several hours or days in advance. To provide personalized, predictive risk alerts 24/7, a team of virtual nurses reviews device data and analyzes trends in the patient's electronic health record.